Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization

Arch Med Res. 1996 Winter;27(4):539-45.

Abstract

In this study we compared natural vs. induced Haemophilus influenzae type b (Hib) anti-capsular polyribosylribitol phosphate (PRP) antibody response in a low socioeconomic population. One hundred twenty five 2-month-old children received the complete HbOC vaccine immunization scheme and a booster dose at 15 months of age. One hundred twenty five non-immunized children served as the control group. Serum Hib anti-PRP antibody titers were determined by ELISA in all children. We found at the end of the primary immunization scheme an antibody concentration of 27.28 micrograms/ml in the immunized group vs. 7.48 micrograms/ml in the control group. The antibody response was mainly of the IgG1 class in both groups. After the booster dose the antibody concentration was 30.14 g/ml in the vaccinated group vs. 6.06 micrograms/ml in the control group (p < 0.01). Ninety nine percent of immunized and non-immunized infants had titers greater than 1 microgram/ml. These results confirm that immunization with the HbOC vaccine induces an important increase in anti-PRP specific antibody titer, but they also demonstrate that natural exposure induces responses higher than those referred as protective (1 microgram/ml).

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Antibodies, Viral / blood*
  • Bacterial Capsules
  • Child, Preschool
  • Clinical Trials as Topic
  • Enzyme-Linked Immunosorbent Assay / methods
  • Erythema
  • Female
  • Fever
  • Haemophilus Infections / prevention & control*
  • Haemophilus Vaccines / immunology*
  • Haemophilus Vaccines / therapeutic use
  • Haemophilus influenzae / immunology*
  • Humans
  • Immunoglobulin Isotypes / blood
  • Male
  • Mexico
  • Polysaccharides, Bacterial / immunology*
  • Polysaccharides, Bacterial / therapeutic use
  • Surveys and Questionnaires
  • Vaccines, Conjugate / administration & dosage
  • Vaccines, Conjugate / immunology*
  • Vaccines, Conjugate / therapeutic use

Substances

  • Antibodies, Viral
  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Immunoglobulin Isotypes
  • Polysaccharides, Bacterial
  • Vaccines, Conjugate